ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.465,69
-0,03%
S&P 500
5.180,74
1,03%
US Dollar vs BRL
5,0762
0,00%
Bitcoin
64.090,14
1,46%
Brent Oil
82,935
-0,65%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Reviva Pharmaceuticals Holdings Inc (RVPH)

  7. Reviva Pharmaceuticals Holdings Inc (RVPH) Notícias

RVPH

Reviva Pharmaceuticals (RVPH)

Reviva Pharmaceuticals Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RVPH
DataHoraFonteTítuloCódigoCompanhia
16/02/202418:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
13/02/202419:00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
02/02/202418:38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202318:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/11/202318:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202318:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202318:03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202317:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/06/202307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202317:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
05/05/202317:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202317:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202309:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202309:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202308:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202318:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/11/202216:35TipRanksReviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Maxim GroupNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/08/202212:25TipRanksMaxim Group Keeps Their Buy Rating on Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/06/202209:35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/03/202208:30GlobeNewswire Inc.Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202217:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/01/202218:15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/01/202208:15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/10/202108:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
03/06/202118:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
28/05/202117:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
28/05/202117:08Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
25/05/202110:22Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RVPH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
MNPR3
MINUPAR ON
BOV
ENAT3
ENAUTA ON
BOV
PRIO3
PETRORIO ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
TELB4
TELEBRAS PN
BOV
COGN3
COGNA ON
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados